Actavis Looks To Keep Up Momentum In Spite Of Yellen's Report
July 16, 2014 at 14:19 PM EDT
Janet Yellen's comments to Congress Tuesday did wonders for biotech stocks, but not in a good way. “Valuation metrics ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.